Clinical-stage biotechnology firm GenFleet Therapeutics has garnered nearly 500 million yuan ($79 million) in its Series C round of financing, per a company statement on Tuesday.
Company Information
Company
Genfleet
Funding Insights
Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
